ロード中...
Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma
Bone marrow plasmacytoid dendritic cells (pDCs) in patients with multiple myeloma (MM) promote tumor growth, survival, drug resistance, and immune suppression. Understanding the molecular signaling crosstalk among the tumor cells, pDCs and immune cells will identify novel therapeutic approaches to e...
保存先:
| 出版年: | Oncogene |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7132141/ https://ncbi.nlm.nih.gov/pubmed/32024967 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-020-1172-0 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|